VTGN
VistaGen Therapeutics Inc
NASDAQ: VTGN · HEALTHCARE · BIOTECHNOLOGY
$0.61
+2.94% today
Updated 2026-04-30
Market cap
$23.64M
P/E ratio
—
P/S ratio
29.96x
EPS (TTM)
$-1.90
Dividend yield
—
52W range
$0 – $5
Volume
0.7M
VistaGen Therapeutics Inc (VTGN) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-6,451.00%
ROE
-101.60%
ROA
-55.50%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2008 | — | $-4754.00 | — | — | — |
| 2009 | — | $-16416.00 | — | — | — |
| 2010 | — | $-21998.00 | — | — | — |
| 2011 | — | $-8976.00 | — | — | — |
| 2012 | $1.34M | $-12.21M | 100.00% | -673.77% | -909.66% |
| 2013 | $200400.00 | $-12.89M | 100.00% | -3,389.77% | -6,430.49% |
| 2014 | $0.00 | $-2.97M | — | — | — |
| 2015 | $-135000.00 | $-13.89M | 100.00% | 5,020.07% | 10,285.78% |
| 2016 | $0.00 | $-47.22M | — | — | — |
| 2017 | $1.25M | $-10.26M | 100.00% | -819.88% | -820.44% |
| 2018 | $0.00 | $-14.35M | — | — | — |
| 2019 | $0.00 | $-24.59M | — | — | — |
| 2020 | $334000.00 | $-20.77M | -30.87% | -5,980.39% | -6,219.76% |
| 2021 | $1.09M | $-17.93M | 100.00% | -1,646.06% | -1,646.09% |
| 2022 | $1.11M | $-47.76M | 100.00% | -4,308.68% | -4,307.19% |
| 2023 | $-227300.00 | $-59.25M | 100.00% | 26,074.79% | 26,065.86% |
| 2024 | $1.06M | $-29.36M | 100.00% | -3,103.48% | -2,759.59% |
| 2025 | $486000.00 | $-51.42M | 100.00% | -11,517.08% | -10,579.84% |